J B Chemicals & Pharmaceuticals Ltd, established in 1976 and one of India’s leading pharmaceutical companies, is an integrated publicly listed organization focused on supplying affordable, quality products in India and globally, trusted by healthcare professionals worldwide.
Financial Highlights:
- Revenues increased 8.39% year-on-year to ₹1,085 crore from ₹1,001 crore.
- Total expenses rose 5.94% to ₹820 crore from ₹774 crore.
- Consolidated net profit grew 18.86% to ₹208 crore from ₹175 crore.
- Earnings per share increased 18.06% to ₹13.27 from ₹11.24.
Stronger profitability was driven by revenue growth outpacing costs, margin expansion, and disciplined operating efficiency across domestic and international businesses.
Outlook:
J B Chemicals & Pharmaceuticals Ltd aims to sustain growth through brand-led domestic expansion, scale-up in international markets, and continued focus on cost optimization and high-return R&D.
Explore the company’s past earnings and latest concall transcripts, click here to visit the AlphaStreet India News Channel.
